News

Cancel
  • Formal opening of “Science Campus Braunschweig-Süd” / 2017

    Life science campus with a focus on translation

    6.10.2017

    On October 6, 2017, the “Science Campus Braunschweig-Süd” was formally opened by Lower Saxony Minister of Science and Culture Gabriele Heinen-Kljajić and Braunschweig’s Oberbürgermeister (Lord Mayor) Ulrich Markurth.

    more info
  • Cardior Pharmaceuticals GmbH (Cardior) is a spin-off company from the Hannover Medical School. Headed by Prof. Dr. Dr. Thomas Thum (CSO) and Dr. Claudia Ulbrich (CEO), its aim is to develop new RNA-based therapeutics for the treatment and prevention of heart disease.

    more info
  • Fraunhofer ITEM is participating in 19 projects submitted under the proof-of-concept initiative that has been launched by the Helmholtz Association, Deutsche Hochschulmedizin (peak organization of German university hospitals and medical schools) and the Fraunhofer-Gesellschaft.

    more info
  • Prize for the academic and scientific video sharing website wissen.hannover.de / 2017

    FOX AWARD GOLD for the Hannover Science Initiative

    Aktuelles / 19.9.2017

    A special award for Hannover as a center of academic and scientific activity: the Hannover Science Initiative has received the FOX AWARD in GOLD 2017 for its video sharing website wissen.hannover.de. Since March 2013, the video sharing website wissen.hannover.de has been used by Hannover’s nine universities and higher-education institutes, the Student Administration, Fraunhofer ITEM, the Volkswagen Foundation, hannoverimpuls GmbH, and the State Capital of Hannover to provide information about academic studies and research in Hannover – always with a focus on science, yet in an entertaining way.

    more info
  • On behalf of the German Federal Ministry of Education and Research, Fraunhofer ITEM has conducted an inhalation toxicity study with nanoparticles. The aim was to close gaps in current knowledge about effects and interactions of nanomaterials with regard to humans and the environment and to enable the safe and responsible use of nanotechnology by German industry.

    more info
  • When it comes to clinical drug studies being carried out by pharmaceutical companies, Germany is once again in second place in the world in 2016. With 532 studies, which were started in 2016, Germany is only beaten in the rankings by the USA (2,306 studies). This is what a study of the public register of studies, clinicaltrials.gov by the German association of research-based pharmaceutical companies (VFA) reveals.

    more info
  • New publication

    News / 2.5.2017

    Fraunhofer ITEM and sterna biologicals GmbH & Co. KG announced that the pre-specified subgroup analysis of patients with high levels of blood eosinophils was published in the Journal of Allergy and Clinical Immunology (Krug et al., 2017).

    more info